Document is current
Any future updates will be listed below
-
Authors
Conticello, Concetta
Fabro, Vittorio Del
Romano, Alessandra
Mele, Anna
Mina, Roberto
Bringhen, Sara
Orofino, Alessandra
Antonioli, Elisabetta
Pulini, Stefano
De Paoli, Lorenzo
Za, Tommaso
Cotzia, Emilia
Elia, Federica
Casson, Andrea
Prete, Eleonora
Citiso, Stefania
Liberatore, Carmine
Margiotta-Casaluci, Gloria
Fazio, Francesca
Morè, Sonia
Attucci, Irene
Accardi, Fabrizio
Bongarzoni, Velia
Mangiacavalli, Silvia
Rossi, Elena
Mannina, Donato
Garibaldi, Bruno
Rizzi, Rita
Di Cecca, Monica
Rossini, Bernardino
Uccello, Giuseppina
Botta, Cirino
Leotta, Dario
Vincelli, Donatella
Gentile, Massimo
Piciocchi, Alfonso
Marsili, Giovanni
Patriarca, Francesca
Zambello, Renato
Musto, Pellegrino
Boccadoro, Mario
Offidani, Massimo
Petrucci, Maria Teresa
Di Raimondo, Francesco
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 26 August 2025
First Online: 7 October 2025
Declarations
:
: The authors declare no competing interests.
: The study was approved bythe independent ethics committee of the coordinating center (n.34/2019/PO). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2024.Informed consent for data processing was obtained from all patients. Carfilzomib-lenalidomide based treatments were performed according to current clinical practice at local institutions.
